Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 16, 2014
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has led a consortium, also comprising Charnwood Technical Consulting, CatScI and Biocatalysts, which has successfully won a Technology Strategy Board grant...
read more
Friday, February 15, 2013
Aesica, the global contract manufacturing organisation (CMO), announces that it will be joining Britest in a collaboration where members share knowledge and risk in defining innovative solutions to key manufacturing challenges.
read more
Aesica Pharmaceuticals, the global pharmaceutical contract development and manufacturing organisation (CDMO), is adding additional services in its oral solids capability including a new roller compaction unit for dry granulation production in Zwickau...
read more
Aesica, the global contract development and manufacturing organisation (CDMO), today announced the appointment of two senior business development positions. Detlef Behrens has been appointed to the role of Vice President, Business Development, ...
read more
Aesica, the global contract development and manufacturing organisation (CDMO), has appointed Sven Thomas and David Ross as business development managers. Their appointment is the next phase in the company’s international drive to increase sales from ...
read more
Thursday, August 29, 2013
Role to oversee a Group wide services of IT, M&A process planning, health and safety, and internal audit system.
read more
Tuesday, February 19, 2013
Aesica, the global contract manufacturing organisation (CMO), and EmulTech, jointly announce the commercial development of ET4ME - an innovative emulsion technology for product formulation.
read more
Two leading global companies, pharmaceutical contract development and manufacturing organisation (CDMO) Aesica and speciality excipient and coating company, Colorcon, are today co-hosting a ground breaking workshop at the Royal College of Physicians ...
read more
Aerie Pharmaceuticals has acquired from Envisia Therapeutics the rights to use PRINT technology in ophthalmology and certain other assets.
read more
Wednesday, October 24, 2018
Aerie has built and commenced operation of its GMP-validated manufacturing facility for production of ophthalmic implants using the proprietary PRINT® Technology platform.
read more
Friday, February 12, 2021
Aerami has announced the signing of an exclusive license and development agreement with Hangzhou Chance to develop and commercialize Aerami’s drug device combination product candidate (AER-901).
read more
Thursday, October 04, 2012
Aenova, a leading provider of development and manufacturing services for medicines and dietary supplements has named Brad Carlson as its new Vice President of Marketing & Sales for the Americas, effective October 1, 2012. Mr. Carlson brings more ...
read more
On July 18, 2022, Neil Jones joined Aenova as the new Chief Commercial Officer (CCO) of Aenova Group.
read more
Thursday, September 15, 2022
The development of new drug products and forms of therapy is progressing rapidly. For contract developers and manufacturers, this means staying on the cutting edge of production technologies and actively supporting customers with innovative ...
read more
Tuesday, October 30, 2012
The Aenova Group, one of the leading companies in the global pharmaceutical and healthcare industry, is in the process of taking over the Temmler Group. An agreement was reached today with the previous owners. The purchase price will remain ...
read more